Lupin Limited (NSE:LUPIN)
India
· Delayed Price · Currency is INR 2,098.80
+6.80 (0.33%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Pharmaceuticals | 226.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 13.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment | -18.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment Growth | 22.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 57.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 57.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Other | 64.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 15.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 85.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 16.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 77.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 8.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 64.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 15.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|